Source: Annual Congress 2006 - Various parenchymal lung diseases and pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. van Wolferen, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf (Amsterdam, Netherlands). Absolute 6-minute walk distance introduces a selection bias in pulmonary hypertension studies. Eur Respir J 2006; 28: Suppl. 50, 2278

Member's Comments

No comment yet.

Related content which might interest you: The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 487-494 Year: 2013 The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1294-1301 Year: 2010 Validation and comparison of reference equations for the 6-min walk distance test Source: Eur Respir J 2008; 31: 571-578 Year: 2008 Interpretation of treatment changes in 6-minute walk distance in patients with COPD Source: Eur Respir J 2008; 32: 637-643 Year: 2008 The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Predictors for longitudinal change in 6-minute walk distance in COPD patients Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1822-1823 Year: 2014 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1823-1824 Year: 2014 Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 767s Year: 2006 Validation of the current equations to estimate peak work load based on 6-min walk distance and general demographics in COPD patients entering pulmonary rehabilitation Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 Estimation of peak work load based on 6-min walk distance and general demographics in patients with COPD: A new regression equation Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Percent predicted six-minute walk distance and prognosis in PAH Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 6-minute walk testing in COPD: is it reproducible? Source: Eur Respir J 2011; 38: 244-245 Year: 2011 The 6-min walking distance: long-term follow up in patients with COPD Source: Eur Respir J 2007; 29: 535-540 Year: 2007 Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004